US Broker Ratings

Grab Holdings Limited (GRAB) Stock Analysis: A 49.44% Potential Upside in the Superapp Space

Grab Holdings Limited (NASDAQ: GRAB), a leading tech powerhouse in Southeast Asia, is capturing investor attention with its robust growth trajectory and formidable presence in the superapp sector. Operating across..

Fastly, Inc. (FSLY) Stock Analysis: Navigating High Valuation with Strong Revenue Growth

Fastly, Inc. (NYSE: FSLY) is making waves in the technology sector with its innovative edge cloud platform. Known for enabling developers to build, secure, and deliver digital experiences at the..

Automatic Data Processing, Inc. (ADP) Stock Analysis: Exploring a 28% Potential Upside

Automatic Data Processing, Inc. (NASDAQ: ADP), a stalwart in the technology sector, operates within the software application industry. With a robust market capitalization of $87.85 billion, ADP offers cloud-based human..

Alpha Teknova, Inc. (TKNO) Stock Analysis: A 343% Upside Potential Beckons Investors

Alpha Teknova, Inc. (NASDAQ: TKNO), a promising player in the healthcare sector, is catching the eye of investors with a notable potential upside of 343.35%. Specializing in the production of..

Full Truck Alliance Co. Ltd. (YMM) Stock Analysis: Investor Outlook on a 38% Upside Potential

As an investor considering opportunities in the technology sector, Full Truck Alliance Co. Ltd. (NYSE: YMM) presents an intriguing proposition with its focus on the software-application industry. Based in Guiyang,..

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Potential Upside of 67.57% Could Attract Investors

For investors scouting for opportunities in the biotechnology sector, Entrada Therapeutics, Inc. (NASDAQ: TRDA) presents a compelling narrative. This Boston-based clinical-stage biopharmaceutical company is pioneering innovative treatments with its proprietary..

Karooooo Ltd. (KARO) Stock Analysis: A Promising 32% Upside Potential Amid Strong Growth Metrics

Karooooo Ltd. (NASDAQ: KARO) stands out in the technology sector with a robust market presence in the Software – Application industry. With its headquarters in Singapore, the company has carved..

Candel Therapeutics, Inc. (CADL) Stock Analysis: Biotech’s Potential 218% Upside Sparks Investor Interest

Candel Therapeutics, Inc. (NASDAQ: CADL), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising pipeline of cancer immunotherapies. Headquartered in Needham, Massachusetts, Candel is strategically..

Mitek Systems, Inc. (MITK) Stock Analysis: Strong Buy Ratings Signal Potential Upside

For investors seeking exposure in the technology sector, particularly in application software, Mitek Systems, Inc. (NASDAQ: MITK) presents an intriguing opportunity. The company, with a market capitalization of $608.6 million,..

Dayforce, Inc. (DAY) Stock Analysis: Navigating the Narrow Price Target with a Focus on Revenue Growth

Dayforce, Inc. (NASDAQ: DAY) stands as a notable player in the technology sector, specifically within the software applications industry. With a market capitalization of $11.18 billion, Dayforce is a significant..

Adobe Inc. (ADBE): Exploring a 57.16% Potential Upside with Strong Revenue Growth

Adobe Inc. (NASDAQ: ADBE), a titan in the technology sector, is renowned for its robust software solutions that cater to a diverse clientele, ranging from creative professionals to enterprise businesses...

Asana, Inc. (ASAN) Investor Outlook: Unveiling a 102% Potential Upside

For investors with a keen interest in technology stocks, Asana, Inc. (ASAN) presents an intriguing opportunity. The company’s recent financial data highlights a potential upside of 102.16%, a figure that..

AMTD Digital Inc. (HKD) Stock Analysis: Exploring the 1,085.90% Revenue Surge in the Software Sector

AMTD Digital Inc. (NYSE: HKD), a Paris-based company operating within the technology sector, has recently caught the attention of investors with its staggering 1,085.90% revenue growth. With a market capitalization..

Roper Technologies, Inc. (ROP) Investor Outlook: Analysts Predict 41% Upside

Roper Technologies, Inc. (NYSE: ROP), a key player in the technology sector with a focus on software applications, is capturing investor attention with an impressive potential upside of 41.08%. This..

Gossamer Bio, Inc. (GOSS) Stock Analysis: Exploring a 334.50% Potential Upside in the Biotech Space

Gossamer Bio, Inc. (NASDAQ: GOSS), a clinical-stage biopharmaceutical company headquartered in San Diego, California, is gaining attention from investors with its promising pipeline in the biotechnology sector. With a market..

Blend Labs, Inc. (BLND) Stock Analysis: Navigating a 167% Potential Upside in the Tech-Driven Financial Sector

For investors eyeing the ever-evolving technology sector, Blend Labs, Inc. (NYSE: BLND) presents a compelling case with its innovative software solutions tailored for the financial services industry. Headquartered in Novato,..

Freshworks Inc. (FRSH) Stock Analysis: Exploring an 80% Potential Upside Amid Strong Analyst Ratings

Freshworks Inc. (NASDAQ: FRSH), a notable player in the technology sector, is currently drawing significant investor interest due to its robust potential upside and positive analyst ratings. With a market..

Jamf Holding Corp. (JAMF) Stock Analysis: Navigating Growth Amidst Challenges in the Apple Ecosystem

Jamf Holding Corp. (NASDAQ: JAMF) stands at the forefront of managing and securing Apple platforms globally, serving a diverse clientele spread across the Americas, Europe, the Middle East, India, Africa,..

Triller Group Inc. (ILLR) Stock Analysis: A Look at Growth Potential Amidst Market Volatility

Triller Group Inc. (ILLR), a Los Angeles-based technology venture known for its AI-powered video-sharing platform, is navigating the volatile waters of the software application industry. With a current market cap..

Neurogene Inc. (NGNE): Investor Outlook with a 232% Potential Upside

Neurogene Inc. (NGNE), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising pipeline of genetic medicines targeting rare neurological diseases. Despite its current challenges in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds